Stephen Ward, MD, PhD
img_Stephen Ward
PROFESSOR | Pathology, Molecular and Cell Based Medicine
Are you a patient?
Specialties
Anatomic Pathology and Clinical Pathology

MD, University of Rochester Nurse Midwifery Program

PhD, University of Maryland

Residency, Pathology - Anatomic/Pathology - Clinical, Bellevue Hospital Center

Publications

Selected Publications

Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: a cross-trial, patient-level analysis. Antonio D'Alessio, Bernardo Stefanini, Julia Blanter, Benjamin Adegbite, Fionnuala Crowley, Vincent Yip, Sarah Slater, Claudia Angela Maria Fulgenzi, Ciro Celsa, Giulia Francesca Manfredi, Madhava Pai, Robert D. Goldin, Stephen C. Ward, Maria Isabel Fiel, Daniel H. Shu, Yung Yeh Su, Alessio Cortellini, Marina Baretti, Robert Anders, Mark Yarchoan, Chiun Hsu, Thomas U. Marron, David J. Pinato. The Lancet Oncology

Single-cell RNA sequencing data identify a conserved population of metallothionein-expressing macrophages that may be ubiquitous in vital human organs. Joseph A. Daccache, Francis Eng, Lei Cao, Ning Ma, Stephen C. Ward, Thomas Schiano, Mark Miller, Daniel Herron, Anthony V. Azzara, Steven S. Pullen, Paolo Guarnieri, Costica Aloman, Andrea D. Branch. Clinical and Translational Discovery

A large-scale retrospective study enabled deep-learning based pathological assessment of frozen procurement kidney biopsies to predict graft loss and guide organ utilization. Zhengzi Yi, Caixia Xi, Madhav C. Menon, Paolo Cravedi, Fasika Tedla, Alan Soto, Zeguo Sun, Keyu Liu, Jason Zhang, Chengguo Wei, Man Chen, Wenlin Wang, Brandon Veremis, Monica Garcia-barros, Abhishek Kumar, Danielle Haakinson, Rachel Brody, Evren U. Azeloglu, Lorenzo Gallon, Philip O'Connell, Maarten Naesens, Ron Shapiro, Robert B. Colvin, Stephen Ward, Fadi Salem, Weijia Zhang. Kidney International

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Ward during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Astrazeneca
  • Martin Clearwater & Bell LLP
  • Intercept Pharm

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.